Improving Cytomegalovirus-Specific T Cell Reconstitution after Haploidentical Stem Cell Transplantation

Improving Cytomegalovirus-Specific T Cell Reconstitution after Haploidentical Stem Cell Transplantation

Cytomegalovirus (CMV) infection and delayed immune reconstitution (IR) remain serious obstacles for successful haploidentical stem cell transplantation (haplo-SCT). CMV-specific IR varied according to whether patients received manipulated/unmanipulated grafts or myeloablative/reduced intensity condi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiao-Hua Luo, Ying-Jun Chang, Xiao-Jun Huang
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2014/631951
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Donor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell Transplantation
by: Piyanuch Kongtim, et al.
Published: (2016-01-01)

Risk factors and clinical outcomes of cytomegalovirus infection following haploidentical hematopoietic stem cell transplantation in patients with aplastic anemia: a single-center retrospective study
by: Jia Feng, et al.
Published: (2025-01-01)

Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation
by: Xiaosu Zhao, et al.
Published: (2017-01-01)

Haploidentical Stem Cell Transplantation: A Gateway to Infrequent Availability of HLA-Matched Related Donors
by: Hafiz Muhammad Aslam, et al.
Published: (2018-01-01)

Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies
by: William A. Fabricius, et al.
Published: (2016-01-01)

Haploidentical stem cell transplantation with posttransplant cyclophosphamide in children with Wiskott–Aldrich syndrome: a case report
by: Le Nguyen Ngoc Quynh, et al.
Published: (2025-02-01)

Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor
by: Federico Meconi, et al.
Published: (2019-01-01)

Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma
by: Eun Seop Seo, et al.
Published: (2025-01-01)

The Combination of Intravenous Immunoglobulin, Dexamethasone, and a High Dose of Mononuclear Cells Transfusion: An Effective Strategy for Decreasing Donor-Specific Antibodies During Haploidentical Hematopoietic Stem Cell Transplantation
by: Xiaoping Li, et al.
Published: (2025-01-01)

UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
by: José Luis Piñana, et al.
Published: (2024-08-01)

Corrigendum: Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma
by: Eun Seop Seo, et al.
Published: (2025-02-01)

The Viral Load of Human Cytomegalovirus Infection in Children following Hematopoietic Stem Cell Transplant by Chip Digital PCR
by: Wen-Jun Wang, et al.
Published: (2022-01-01)

Haploidentical hematopoietic stem cell transplantation using post-transplant cyclophosphamide in patients with inborn errors of immunity: Experience in a reference center in Colombia
by: Diego Medina, et al.
Published: (2024-12-01)

Reconstitution Properties of Thymus Stem Cells in Murine Fetal Liver
by: Hilary J. Mckenna, et al.
Published: (1994-01-01)

Enhancement of Cytomegalovirus-Specific Cytokine Production after Modulation of the Costimulation in Kidney Transplant Patients
by: Theresa Dornieden, et al.
Published: (2019-01-01)

Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow—Review of Published Literature
by: Shatha Farhan, et al.
Published: (2016-01-01)

Haploidentical Family Donor Transplantation: At the Crossroads of a Changing Paradigm
by: Suparno Chakrabarti, et al.
Published: (2016-01-01)

Cytomegalovirus Pathogenesis in Transplantation
by: Jane E Grundy
Published: (1993-01-01)

Clinical Characteristics and Prognostic Factors Affecting Clinical Outcomes in Cytomegalovirus Retinitis Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Qiaozhu Zeng, et al.
Published: (2025-01-01)

A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies
by: Melhem M. Solh, et al.
Published: (2021-01-01)

Prophylaxis of Cytomegalovirus in Renal Transplant Recipients
by: Allan S MacDonald, et al.
Published: (1993-01-01)

Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells
by: Francesco Orio, et al.
Published: (2014-01-01)

Clinical Factors Influencing Phenotype of HCMV-Specific CD8+ T Cells and HCMV-Induced Interferon-Gamma Production after Allogeneic Stem Cells Transplantation
by: Inmaculada Gayoso, et al.
Published: (2013-01-01)

Regulatory T Cells in Allogeneic Stem Cell Transplantation
by: Maria Michael, et al.
Published: (2013-01-01)

HAPLOIDENTICAL TRANSPLANT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS: THE ROLE OF PREVIOUS LINES OF THERAPY.
by: Daniele Avenoso, et al.
Published: (2024-01-01)

Prevention and Treatment of Cytomegalovirus Infection in Transplant Recipients
by: Jutta K Preiksatis
Published: (1993-01-01)

Intrasplenic Transplantation of Bioencapsulated Mesenchymal Stem Cells Improves the Recovery Rates of 90% Partial Hepatectomized Rats
by: Zun Chang Liu, et al.
Published: (2012-01-01)

Novel Strategies for the Improvement of Stem Cells’ Transplantation in Degenerative Retinal Diseases
by: Simona Delia Nicoară, et al.
Published: (2016-01-01)

Cytomegalovirus Infection in Patient with Clear Cell Renal Cell Carcinoma
by: Ikhwan Rinaldi, et al.
Published: (2023-01-01)

Generation of Transplantable Beta Cells for Patient-Specific Cell Therapy
by: Xiaojie Wang, et al.
Published: (2012-01-01)

Autoimmune Complications after Hematopoietic Stem Cell Transplantation in Children with Nonmalignant Disorders
by: Abdalla Khalil, et al.
Published: (2014-01-01)

Potential Role of the Resident Mesenchymal Stem-Like Cells in Renal Fibrogenesis after Ureteral Obstruction
by: Yong-Hua Peng, et al.
Published: (2019-01-01)

Prevention and management of cytomegalovirus infection and disease in kidney transplant: A consensus statement of the Transplantation Society of Taiwan
by: Mu-Chi Chung, et al.
Published: (2025-02-01)

NKG2C+CD57+ Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8+ T Cell Evolution towards Senescence
by: John Heath, et al.
Published: (2016-01-01)

Pure Red Cell Aplasia due to B19 Parvovirus Infection after Autologous Stem Cell Transplantation
by: Panagiotis Tsirigotis, et al.
Published: (2011-01-01)

Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation
by: Håkon Reikvam, et al.
Published: (2018-01-01)

Brincidofovir Use after Foscarnet Crystal Nephropathy in a Kidney Transplant Recipient with Multiresistant Cytomegalovirus Infection
by: Romain Vial, et al.
Published: (2017-01-01)

Cytomegalovirus and Human Herpesvirus 6 and 7: Diseases and Diagnosis in Transplantation
by: Paul D Griffiths
Published: (1993-01-01)

Specific Blood Cells Derived from Pluripotent Stem Cells: An Emerging Field with Great Potential in Clinical Cell Therapy
by: Qian Luo, et al.
Published: (2021-01-01)

HA14-1 is Able to Reconstitute the Impaired Mitochondrial Pathway of Apoptosis in Renal Cell Carcinoma Cell Lines
by: Sebastian Heikaus, et al.
Published: (2008-01-01)